オプションチェーンは、Webuy Globalの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Webuy Globalの市場センチメントを評価します。.

Webuy Global (NASDAQ:WBUY) 株価情報, オプションチェーン

Webuy Global

Webuy Global Ltd is an emerging Southeast Asian (SEA) community-oriented e-commerce retailer (Community e-Commerce Retailor) with a focus on grocery and travel. Community e-commerce is a deepened extension form of e-commerce, where social media users with mutual interest and like-minded behavior are connected, forming a community group within a network through an online medium. Its mission is to make social shopping a new lifestyle for consumers and to empower consumers' purchases with an efficient cost-saving purchasing model. The company is also engaged in selling packaged tours to its customers. The majority of revenue is derived from the sales of groceries through its online platform. Its geographic areas are Singapore, Indonesia, and Malaysia.

Webuy Global Ltd

Olo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLO#NYSE">OLO</a>) sees Q4 sales of $72.500 million-73.000 million vs $72.13 million estimate.

News

Guidance

Olo Sees Q4 Sales $72.500M-73.000M vs $72.13M Est

Management

Unity Names Jarrod Yahes As CFO

Nerdy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRDY#NYSE">NRDY</a>) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.23) by 39.13 percent. This is a 55.56 percent decrease over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $37.530 million which beat the analyst consensus estimate of $36.670 million by 2.34 percent. This is a 6.86 percent decrease over sales of $40.296 million the same period last year.

Earnings

Earnings Beats

NRDY

Nerdy Q3 2024 GAAP EPS $(0.14) Beats $(0.23) Estimate, Sales $37.530M Beat $36.670M Estimate

FormFactor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) and Advantest Corporation (TSE: 6857) announced today a strategic partnership to develop a novel test cell and measurement system designed for high-volume production of silicon photonics (SiPh) and co-packaged optics (CPO) devices. This collaboration is driven by the revolution in AI data center architectures, which require ever-increasing bandwidth while reducing power consumption. Silicon photonics is rapidly gaining traction in data centers for its ability to enable fast data transmission through optical signals, surpassing traditional electrical methods. This new test cell integrates the latest innovations from both companies, equipping photonics device developers with the tools they need to scale up volume production.

FORM

FormFactor And Advantest Partner On Silicon Photonics Wafer-Level Test Cell To Enable High-Volume Manufacturing

ARKO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKO#NASDAQ">ARKO</a>) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.12 by 41.67 percent. This is a 58.82 percent decrease over earnings of $0.17 per share from the same period last year. The company reported quarterly sales of $2.28 billion which missed the analyst consensus estimate of $2.41 billion by 5.44 percent. This is a 13.08 percent decrease over sales of $2.62 billion the same period last year.

Earnings Misses

ARKO

ARKO Q3 EPS $0.07 Misses $0.12 Estimate, Sales $2.28B Miss $2.41B Estimate

Offerings

PRPH

ProPhase Labs Announced That Intends To Sell Shares Of Its Common Stock In An Underwritten Public Offering; Terms Not Disclosed

Definitive Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DH#NASDAQ">DH</a>) is looking for Q4 Adj EPS of $0.07 vs $0.07 analyst estimate. seessales of $60.000 million-61.000 million vs $60.28 million estimate.

Definitive Healthcare Sees Q4 Adj EPS $0.07 vs $0.07 Est; Sees Sales $60.000M-61.000M vs $60.28M Est

NWSA

News Corp Appoints Lavanya Chandrashekar As CFO; Succeeds Susan Panuccio

Definitive Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DH#NASDAQ">DH</a>) raises FY2024 Adj EPS guidance from $0.32-0.34 to $0.34-0.35 vs $0.33 analyst estimate. Raises FY2024 sales outlook from $247.00 million-251.00 million to $250.00 million-251.00 million vs $249.23 million estimate.

Definitive Healthcare Raises FY2024 Adj EPS Guidance from $0.32-0.34 to $0.34-0.35 vs $0.33 Est; Raises FY2024 Sales Guidance from $247.00M-251.00M to $250.00M-251.00M vs $249.23M Est

TruBridge (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBRG#NASDAQ">TBRG</a>) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $0.27 by 177.78 percent. The company reported quarterly sales of $83.800 million which beat the analyst consensus estimate of $82.870 million by 1.12 percent. This is a 1.32 percent increase over sales of $82.712 million the same period last year.

TBRG

TruBridge Q3 2024 Adj. EPS $(0.21) Misses $0.27 Estimate, Sales $83.800M Beat $82.870M Estimate

ClearPoint Neuro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLPT#NASDAQ">CLPT</a>) affirms FY2024 sales outlook from $30.00 million-33.00 million to $30.00 million-33.00 million.

CLPT

ClearPoint Neuro Affirms FY2024 Sales Guidance from $30.00M-33.00M to $30.00M-33.00M

Nephros (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEPH#NASDAQ">NEPH</a>) reported quarterly sales of $3.50 million which met the analyst consensus estimate. This is a 6.47 percent decrease over sales of $3.74 million the same period last year.

NEPH

Nephros Q3 Sales $3.50M Inline

SYNA

Synaptics Sees Q2 2025 Revenue $265M +/- $15M

TPI Composites (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPIC#NASDAQ">TPIC</a>) reported quarterly losses of $(0.84) per share which missed the analyst consensus estimate of $(0.15) by 460 percent. This is a 50.88 percent increase over losses of $(1.71) per share from the same period last year. The company reported quarterly sales of $380.76 million which beat the analyst consensus estimate of $367.90 million by 3.50 percent. This is a 2.12 percent increase over sales of $372.86 million the same period last year.

TPIC

TPI Composites Q3 2024 Sales $380.76M Beat $367.90M Estimate

One Group Hospitality (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKS#NASDAQ">STKS</a>) raises FY2024 sales outlook from $700.00 million-740.00 million to $844.00 million-864.00 million.

STKS

One Group Hospitality Raises FY2024 Sales Guidance from $700.00M-740.00M to $844.00M-864.00M

Adaptive Biotechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADPT#NASDAQ">ADPT</a>) raises FY2024 sales outlook from $140.00 million-145.00 million to $143.00 million-145.00 million.

ADPT

Adaptive Biotechnologies Raises FY2024 Sales Guidance from $140.00M-145.00M to $143.00M-145.00M

Regulus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGLS#NASDAQ">RGLS</a>) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.17) by 23.53 percent. This is a 47.5 percent increase over losses of $(0.40) per share from the same period last year.

RGLS

Regulus Therapeutics Q3 EPS $(0.21) Misses $(0.17) Estimate

Affirm Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) reported its first-quarter results after Thursday's closing bell. Here's a look at the key <a href="https://www.benzinga.com/pressreleases/24/11/b41823677/affirm-reports-first-fiscal-quarter-2025-results">figures from the quarter.   </a>
The Details: Affirm reported quarterly losses of 31 cents per share, which beat the analyst consensus estimate for losses of 35 cents. Quarterly revenue came in at $698.47 million which beat the analyst consensus estimate of $664.01 million and is an increase over sales of $496.54 million from the same period last year.
Read Next: <a href="https://www.benzinga.com/news/24/11/41781921/what-does-trumps-victory-mean-for-ev-giant-tesla-and-the-big-3-automakers">What Does Trump&#8217;s Victory Mean For EV Giant Tesla And The Big 3 Automakers?</a>
&#8220;We continued driving accelerated growth while delivering consistent credit outcomes and managing the business to our target of 3-4% RLTC as a percentage of GMV, which stood at 3.8% this quarter. Year-over-year GMV growth re-accelerated, and growth in active consumers accelerated for the third consecutive quarter,&#8221; said Max Levchin, Affirm&#8217;s CEO.
&#8220;Transactions per active consumer grew 25% year over year to 5.1, and trailing 12-month GMV per active consumer grew 11% year over year to $1,500. We continue to expect to reach GAAP Operating Income profitability in FQ4'25,&#8221; Levchin added.
Outlook:&nbsp;Affirm sees second-quarter revenue of between $770 million and $810 million and fiscal year 2025 GMV of more than $34 billion. 
AFRM Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Affirm shares are down 0.71% after-hours at $48.45 at the time of publication Thursday.
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/11/41822473/trumps-potential-health-czar-robert-f-kennedy-jr-rattles-vaccine-stocks-shoot-first-reaction">Trump&#8217;s Potential &#8216;Health Czar&#8217; Robert F. Kennedy Jr. Rattles Vaccine Stocks: &#8216;Shoot First Reaction&#8217;</a></li>
</ul>
Photo: Shutterstock

Fintech news covering the emerging Financial Technology services sector

Fintech

Movers

AFRM

Affirm Reports Better-Than-Expected Q1 Results: Details

WIIM

INOD

Innodata shares are trading higher after the company reported better-than-expected Q3 financial results.

Lions Gate Entertainment Corporation Class B Non-Voting Shares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LGF#NYSE">LGF</a>) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.65) by 33.85 percent. The company reported quarterly sales of $948.600 million which missed the analyst consensus estimate of $956.789 million by 0.86 percent. This is a 6.63 percent decrease over sales of $1.016 billion the same period last year.

Lions Gate Entertainment Corporation Class B Non-Voting Shares

LGF/B

Lions Gate Entertainment Corporation Class B Non-Voting Shares Q2 2025 Adj. EPS $(0.43) Beats $(0.65) Estimate, Sales $948.600M Miss $956.789M Estimate

Webuy Global Ltd. (WBUY) has released an update. Webuy Global Ltd. has expanded into the nutraceutical and longevity markets with its new premium h...

Webuy Global Dives Into Nutraceutical Market

Webuy Global Ltd. (WBUY) has released an update. Webuy Global Ltd. has been notified by Nasdaq of non-compliance with the minimum bid price require...

Webuy Global Risks Nasdaq Delisting Over Stock Price

Webuy Global gets Nasdaq extension to regain compliance

Webuy Global Ltd. (WBUY) has released an update. Webuy Global Ltd. has entered into a Securities Purchase Agreement with Lind Global Fund II LP, ma...

Webuy Global Enters Key Investment Agreement

Webuy secures $2M debt financing convertible at premium to current market price

Webuy Global files for secondary common stock offering

Webuy Global HY gross profit jumps 253% to $2.6M; stock rises

Webuy Global Ltd. (WBUY) has released an update. Webuy Global Ltd. reports a 15.4% increase in revenue for the first half of 2024, driven by a nota...

Webuy Global Reports Revenue Growth Amidst Net Loss

&nbsp;&nbsp;Webuy Global Ltd reports 1H results

Warning: WBUY is at high risk of performing badly

WBUY

Press Releases

Presenting on the Emerging Growth Conference 70 Day 2 on May 9 Register Now

Webuy Launches Travel Business in Indonesia

General

Webuy Announces Strategic Expansion into Insurance Referral Program

Webuy Announces Entry into the Nutraceutical and Longevity Markets with the Launch of Flagship Brand NEONE: A Premium Health Supplement

Webuy Announces the Launch of its Sing Select Gift  Series—a New Line of Premium Gift Sets

Webuy Receives Extension to Regain Compliance  with Nasdaq's Minimum Bid Requirements

Webuy Secures $2 Million Debt Financing Convertible at a Premium to the Current Market Price; Potential to Receive an Additional $4.0 Million Upon Mutual Agreement of the Parties

Webuy Achieves Record $2.9 Million in Sales  within Just Three Days at NATAS Fair 2024

Webuy Global Reports Record Revenue and 253% Increase in Gross Profit for the First Half of 2024

"Stocks Under $1 Gaining Momentum: WBUY, KAVL, OMEX, PRTG, RJDG – Driving Innovation, Market Trends, and Growth Potential"

BIXT

CSE:FNDX

CSE:MILK

DBMM

FDXTF

IDEX

IMRN

ISRJF

KAVL

LGMK

MAXQF

MHUA

NCSM

OMEX

OPHC

OWLT

PLVFF

PRTG

RGBP

RJDG

SIGYD

STRW

TSX:URE

TSXV:GIII

ZDPY

Albertsons Companies, Inc. Class A Common Stock

Albertsons Companies

Maplebear

Caseys General Stores, Inc. - Common Stock

Casey's General Stores

Chanson International Holding - Class A Ordinary Shares

Chanson International

Dingdong (Cayman) Limited American Depositary Shares (each two representing three Ordinary Shares)

Comments

Webuy Global

Webuy Global (WBUY) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル